Peripheral Neuropathy Trial, Recruiting (NCT04533152)

Peripheral Neuropathy Trial, Recruiting NCT04533152 Sponsor: University Hospital, Bordeaux Condition: Peripheral Neuropathy

Printed from Voxsanity (voxsanity.com.au) — NCT04533152 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Neuropathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults who have diabetes and a foot ulcer or open wound on the foot or lower leg, located below the ankle bone, caused by complications of diabetes, and measuring at least 5 mm across.
People who had an amputation before joining the trial — in that case, the amputation site (stump) would be treated as the main wound being studied, not the original wound that led to the amputation.

Who may not be able to join:

People who have reduced blood flow to the lower leg or foot but do not have an open skin wound.
People who have a foot infection but do not have an open skin wound.
People who have another illness or condition that would prevent safe participation in an observational study (confirm with trial site).
People who are pregnant or breastfeeding.
People who are under a legal protection arrangement such as curatorship or guardianship.
People who are currently in prison.
People who are already taking part in more than one other clinical study at the same time (the trial site allows participation in a maximum of two studies total, including this one).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 5 57 65 60 78

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04533152

Sponsor: University Hospital, Bordeaux

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Neuropathy

Trial contact: 5 57 65 60 78

More information: https://clinicaltrials.gov/study/NCT04533152

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults who have diabetes and a foot ulcer or open wound on the foot or lower leg, located below the ankle bone, caused by complications of diabetes, and measuring at least 5 mm across.
People who had an amputation before joining the trial — in that case, the amputation site (stump) would be treated as the main wound being studied, not the original wound that led to the amputation.

Who may not be able to join:

People who have reduced blood flow to the lower leg or foot but do not have an open skin wound.
People who have a foot infection but do not have an open skin wound.
People who have another illness or condition that would prevent safe participation in an observational study (confirm with trial site).
People who are pregnant or breastfeeding.
People who are under a legal protection arrangement such as curatorship or guardianship.
People who are currently in prison.
People who are already taking part in more than one other clinical study at the same time (the trial site allows participation in a maximum of two studies total, including this one).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Bordeaux

Registry

ClinicalTrials.gov

Start date

24 November 2021

Est. completion

1 November 2029

Where this trial is recruiting

🇫🇷 France Martinique

Primary endpoints

DFU risk score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov